Skip to Content

AstraZeneca COVID-19 Vaccine Approved by the WHO

TUESDAY, Feb. 16, 2021 -- The AstraZeneca COVID-19 vaccine has received emergency use authorization from the World Health Organization.

Monday's approval for vaccines from the Serum Institute of India and South Korea's AstraZeneca-SKBio could lead to hundreds of millions of doses being delivered to countries participating in the U.N.-supported COVAX program, which seeks to provide vaccines to the world's most vulnerable people, the Associated Press reported.

"Countries with no access to vaccines to date will finally be able to start vaccinating their health workers and populations at risk," said Mariângela Simão, M.D., the WHO assistant-director general for access to medicines and health products.

The AstraZeneca vaccine, which has already been approved in more than 50 countries, forms the bulk of the COVAX stockpile, and concerns were recently raised after an early study suggested it might not prevent mild and moderate disease caused by a more contagious variant first seen in South Africa. Last week, South Africa scaled back its planned rollout of the AstraZeneca vaccine, opting instead to use an unlicensed shot from Johnson & Johnson for its health care workers, the AP reported.

This is only the second such approval from the WHO, which gave the Pfizer vaccine the green light in December.

Associated Press Article

© 2021 HealthDay. All rights reserved.

Read this next

Physician's Briefing Weekly Coronavirus Roundup

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of March 1 to 5, 2021. This roundup...

Shortage of Syringes Reported for COVID-19 Shots

FRIDAY, March 5, 2021 -- Countries worldwide are struggling to find enough syringes to administer COVID-19 vaccines. Experts say between 8 billion and 10 billion syringes are...

Two Cases of SARS-CoV-2 Variant P.1 Identified in Minnesota

FRIDAY, March 5, 2021 -- Two cases of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant P.1 identified in Minnesota are described in a report published in...

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of in your inbox.